Aladin+ fall detection device: test protocol and results
Learn what a Domalys testing campaign observed across more than 300 simulated fall trials, how scenarios were selected and which limitations matter.
In brief. a Domalys trial campaign inspired by TASDA test scenarios reported over 300 trials, 93% detection of tested falls and no false positives observed during the campaign. These are test results, not a TASDA certification or a clinical guarantee.
What was tested and why?
Domalys describes a campaign of more than 300 trials to evaluate Aladin+ on several types of fall rather than relying on a single standardized motion. The trials were inspired by the TASDA protocol.
The account says the campaign was conducted under the observation of a judicial officer (huissier de justice) to document the test process. This does not in itself establish clinical validation, independent certification or universal real-world performance.
Test protocol and scenarios
The campaign considered conventional falls, slower or softer collapses and events involving a recovery attempt. Testing varied scenarios matters because falls are not always sudden, vertical movements.
Trials inspired by the TASDA protocol, without a claim of certification.
More than 300 trial runs in the documented campaign.
Conventional, slow and soft falls, plus recovery attempts.
40 scenarios were performed with three volunteers on one day of testing.
The original French documentation describes 40 scenarios with three volunteers during a complete test day. This is a detail of the recorded session, not the total number of trials in the campaign.
What does the 93% detection figure mean?
The reported detection figure means that 93% of the fall situations tested during the campaign triggered a detection. This percentage applies to that particular test sample and setup.
It does not establish a 93% detection probability for every nursing home, room, resident movement or installation. The tested scenarios may differ from real events, and the source does not report a clinical validation population.
No false positives observed: the limitation
A false positive is an alert triggered when the target event did not occur. Domalys reports no false positives in the tested campaign.
This observation should not be interpreted as a guarantee that false alerts can never occur. The duration, conditions, settings and range of tested non-fall movements determine what can be concluded.
Why different fall scenarios matter
Some events are fast, while others involve a gradual slide, a partial recovery or an atypical movement. Testing a variety of scenarios helps reveal whether detection depends heavily on a narrow motion pattern.
However, diversity of scripted trials alone does not demonstrate effectiveness for every resident or environment. A complete deployment review must also examine the room layout, detection coverage and caregiver response workflows.
What the campaign demonstrates — and what it does not
- The report documents more than 300 trials across several scripted fall scenarios.
- The observed detection proportion was 93% within that campaign.
- No false positives were observed during the described trials.
- The study is not a clinical trial involving a real population of residents.
- The tests should not be called TASDA certification.
- The findings do not guarantee an identical result across installations.
- Care-team training and response procedures are outside the scope of the detection percentage.
From a test result to nursing home use
Field experiences in nursing homes and technical tests provide different types of evidence. A site deployment also requires considering lighting, bed-exit settings, room coverage, notifications, local procedures and staff workflows.
This article is dedicated to the campaign’s results. Product features, installation requirements and commercial information are documented separately on the Aladin+ page.
Explore fall detection and related resources
Frequently asked questions
How many Aladin+ trials were carried out?
The reported campaign covered more than 300 trials with several fall scenarios.
What detection result was reported?
The campaign reported detection of 93% of tested fall situations under the conditions described.
Were any false positives observed?
None were reported during that campaign. This does not rule out false alerts in real-world installations.
Was Aladin+ certified by TASDA through these trials?
No. The original account says that scenarios were inspired by the TASDA protocol; it does not describe a TASDA certification.
What kinds of falls were tested?
Conventional, slow and soft falls, together with scenarios involving an attempt to recover.
Is the 93% figure a clinical performance guarantee?
No. It is an observed result in the test campaign, not a guarantee for every room, resident or nursing home.
How should a nursing home evaluate Aladin+?
Review its coverage, room conditions, staff notifications, local procedures and product documentation before a deployment.
Explore Aladin+ for your facility
Review technical specifications, installation conditions and the way alerts reach care teams.
French source adapted into US English. Interview excerpts may be condensed; figures and descriptions remain limited to the documented campaign or French facility.